David Gomez-Varela

David Gomez-Varela

Auto-generated profile, based on publicly available information

David Gomez-Varela

Max-Planck Institute of Experimental Medicine, Somatosensory Signaling and Systems Biology Group, Goettingen, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2018 in eLife
Verified
Journal Article
Open access
PNPratibha Narayanan
Pratibha Narayanan
MHMeike Hütte
Meike Hütte
GKGalina Kudryasheva
Galina Kudryasheva
FTFrancisco J Taberner
Francisco J Taberner
SLStefan G Lechner
Stefan G Lechner
MSManuela Schmidt
Manuela Schmidt
Piezo2 ion channels are critical determinants of the sense of light touch in vertebrates. Yet, their regulation is only incompletely understood. We recently identified myotubularin related protein-2 (Mtmr2), a phosphoinositide (PI) phosphatase, in the native Piezo2 interactome of murine dorsal root ganglia (DRG). Here, we demonstrate that Mtmr2 attenuates Piezo2-mediated rapidly adapting mechanically activated (RA-MA) currents. Interestingly, heterologous Piezo1 and other known MA current subtypes in DRG appeared largely unaffected by Mtmr2. Experiments with catalytically inactive Mtmr2, pharmacological blockers of PI(3,5)P2 synthesis, and osmotic stress suggest that Mtmr2-dependent Piezo2 inhibition involves depletion of PI(3,5)P2. Further, we identified a PI(3,5)P2 binding region in Piezo2, but not Piezo1, that confers sensitivity to Mtmr2 as indicated by functional analysis of a domain-swapped Piezo2 mutant. Altogether, our results propose local PI(3,5)P2 modulation via Mtmr2 in the vicinity of Piezo2 as a novel mechanism to dynamically control Piezo2-dependent mechanotransduction in peripheral sensory neurons.

20 March 2017 in Proteomics
Verified
Journal Article
Closed access
PDF file
RBRoland Bruderer
Roland Bruderer
JSJulia Sondermann
Julia Sondermann
CTChih‐Chiang Tsou
Chih‐Chiang Tsou
ABAlonso Barrantes‐Freer
Alonso Barrantes‐Freer
CSChristine Stadelmann
Christine Stadelmann
DGDavid Gomez‐Varela
David Gomez‐Varela

20 January 2021 in Pain
Verified
Journal Article
Open access
EPEsther Miriam Pogatzki-Zahn
Esther Miriam Pogatzki-Zahn
DGDavid Gomez-Varela
David Gomez-Varela
GEGerrit Erdmann
Gerrit Erdmann
KKKatharina Kaschube
Katharina Kaschube
DSDaniel Segelcke
Daniel Segelcke
MSManuela Schmidt
Manuela Schmidt
After surgery, acute pain is still managed insufficiently and may lead to short-term and long-term complications including chronic postsurgical pain and an increased prescription of opioids. Thus, identifying new targets specifically implicated in postoperative pain is of utmost importance to develop effective and nonaddictive analgesics. Here, we used an integrated and multimethod workflow to reveal unprecedented insights into proteome dynamics in dorsal root ganglia (DRG) of mice after plantar incision (INC). Based on a detailed characterization of INC-associated pain-related behavior profiles, including a novel paradigm for nonevoked pain, we performed quantitative mass-spectrometry–based proteomics in DRG 1 day after INC. Our data revealed a hitherto unknown INC-regulated protein signature in DRG with changes in distinct proteins and cellular signaling pathways. In particular, we show the differential regulation of 44 protein candidates, many of which are annotated with pathways related to immune and inflammatory responses such as MAPK/extracellular signal-regulated kinases signaling. Subsequent orthogonal assays comprised multiplex Western blotting, bioinformatic protein network analysis, and immunolabeling in independent mouse cohorts to validate (1) the INC-induced regulation of immune/inflammatory pathways and (2) the high priority candidate Annexin A1. Taken together, our results propose novel potential targets in the context of incision and, therefore, represent a highly valuable resource for further mechanistic and translational studies of postoperative pain.

14 August 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
ABAllison M. Barry
Allison M. Barry
JSJulia R. Sondermann
Julia R. Sondermann
JSJan-Hendrik Sondermann
Jan-Hendrik Sondermann
DGDavid Gomez-Varela
David Gomez-Varela
MSManuela Schmidt
Manuela Schmidt
To obtain a thorough understanding of chronic pain, large-scale molecular mapping of the pain axis at the protein level is necessary, but has not yet been achieved. We applied quantitative proteome profiling to build a comprehensive protein compendium of three regions of the pain neuraxis in mice: the sciatic nerve (SN), the dorsal root ganglia (DRG), and the spinal cord (SC). Furthermore, extensive bioinformatics analysis enabled us to reveal unique protein subsets which are specifically enriched in the peripheral nervous system (PNS) and SC. The immense value of these datasets for the scientific community is highlighted by validation experiments, where we monitored protein network dynamics during neuropathic pain. Here, we resolved profound region-specific differences and distinct changes of PNS-enriched proteins under pathological conditions. Overall, we provide a unique and validated systems biology proteome resource (summarized in our online database www.painproteome.em.mpg.de), which facilitates mechanistic insights into somatosensory biology and chronic pain – a prerequisite for the identification of novel therapeutic targets.

28 August 2006 in FEBS Letters
Verified
Journal Article
Closed access
DGDavid Gómez-Varela
David Gómez-Varela
CCConstanza Contreras-Jurado
Constanza Contreras-Jurado
SFSimone Furini
Simone Furini
RGRafael García-Ferreiro
Rafael García-Ferreiro
WSWalter Stühmer
Walter Stühmer
Luis PardoLuis Pardo
Luis Pardo

22 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RKRiku Klén
Riku Klén
DPDisha Purohit
Disha Purohit
RGRicardo Gómez-Huelgas
Ricardo Gómez-Huelgas
JCJosé Manuel Casas-Rojo
José Manuel Casas-Rojo
JSJuan Miguel Antón Santos
Juan Miguel Antón Santos
DGDavid Gómez-Varela
David Gómez-Varela
Background More contagious SARS-CoV-2 virus variants, breakthrough infections, waning immunity, and differential access to COVID-19 vaccines account for the worst yet numbers of hospitalization and deaths during the COVID-19 pandemic, particularly in resource-limited countries. There is an urgent need for clinically valuable, generalizable, and parsimonious triage tools assisting appropriate allocation of hospital resources during the pandemic. We aimed to develop and extensively validate a machine learning-based tool for accurately predicting the clinical outcome of hospitalized COVID-19 patients. Methods CODOP was built using modified stable iterative variable selection and linear regression with lasso regularisation. To avoid generalization problems, CODOP was trained and tested with three time-sliced and geographically distinct cohorts encompassing 40 511 blood-based analyses of COVID-19 patients from more than 110 hospitals in Spain and the USA during 2020-21. We assessed the discriminative ability of the model using the Area Under the Receiving Operative Curve (AUROC) as well as horizon and Kaplan-Meier risk stratification analyses. To reckon the fluctuating pressure levels in hospitals through the pandemic, we offer two online CODOP calculators suited for undertriage or overtriage scenarios. We challenged their generalizability and clinical utility throughout an evaluation with datasets gathered in five hospitals from three Latin American countries. Findings CODOP uses 12 clinical parameters commonly measured at hospital admission and associated with the pathophysiology of COVID-19. CODOP reaches high discriminative ability up to nine days before clinical resolution (AUROC: 0·90-0·96, 95% CI 0·879-0·970), it is well calibrated, and it enables an effective dynamic risk stratification during hospitalization. The two CODOP online calculators predicted the clinical outcome of the majority of patients (73-100% sensitivity and 84-100% specificity) from the distinctive Latin American evaluation cohort. Interpretation The high predictive performance of CODOP in geographically disperse patient cohorts and the easiness-of-use, strongly suggest its clinical utility as a global triage tool, particularly in resource-limited countries. Funding The Max Planck Society. Evidence before this study We have searched PubMed for articles about the existence of in-hospital COVID-19 mortality predictive models, using the search terms “coronavirus”, “COVID-19”, “risk”, “death”, “mortality”, and “prediction”, focusing on studies published between March 1, 2020 and 31 August, 2021. The studies we identified generally used small-medium size cohorts of patients that are geographically restricted to small regions of the developed world (many times, to the same city). We haven’t found studies that challenged their models in cohorts of patients from distinct health system populations, particularly from resource-limited countries. Further, all previous models are rigid by not acknowledging the fluctuating availability of hospital resources during the pandemic (e.g., beds, oxygen supply). These and other limitations have been pointed out by expert reviews indicating that published in-hospital COVID-19 mortality predictive models are subject to high risk of bias, report an over-optimistic performance, and have limited clinical value in assisting daily triage decisions. A parsimonious, accurate and extensively validated model is yet to be developed. Added value of this study We analysed clinical data from different cohorts totalling 21 607 COVID-19 patients treated in more than 110 hospitals in Spain and the USA during three different pandemic waves extending from February 2020 to April 2021. The new CODOP in-hospital mortality prediction model is based on 11 blood biochemistry parameters (representing main biological pathways involved in the pathogenesis of SARS-CoV-2) plus Age, all of them commonly measured upon hospitalization, even in resource-limited countries. CODOP accurately predicted mortality risk up to nine days before clinical resolution (AUROC: 0·90-0·96, 95% CI 0·879-0·970), it is well calibrated, and it enables an effective dynamic risk stratification during hospitalization. As a unique characteristic, we offer two online CODOP calculator subtypes (https://gomezvarelalab.em.mpg.de/codop/) tailored to overtriage and undertriage scenarios. The online calculators were able to correctly predict the clinical outcome of the majority of patients of five independent evaluation cohorts gathered hospitals of three Latin American countries from March 7th 2020 to June 7th 2021. Implications of all the available evidence We present here a highly accurate, parsimonious and extensively validated COVID-19 in-hospital mortality prediction model, derived from working with the largest number and the most geographically extended representation of patients and health systems to date. The rigorous analytical methods, the generalizability of the model in distinct world regions, and its flexibility to reckon with the changing availability of hospital resources point to CODOP as a clinically useful tool potentially improving the outcome prediction and the management of COVID-19 hospitalized patients.